Multiple Sclerosis, Primary Progressive

Neurology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

MediciNova
MediciNovaLA JOLLA, CA
1 program
1
ibudilastPhase 21 trial
Active Trials
NCT01982942Completed255Est. Dec 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MediciNovaibudilast

Clinical Trials (1)

Total enrollment: 255 patients across 1 trials

NCT01982942MediciNovaibudilast

Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis

Start: Nov 2013Est. completion: Dec 2017255 patients
Phase 2Completed

Related Jobs in Neurology

Director, Distribution & Services

Xenon Pharmaceuticals
Remote
13h ago

Senior Medical Science Liaison (NYC Tri-State)

Xenon Pharmaceuticals
Remote
13h ago
$208K - $234K/yr

Director of Medical Affairs

CoMind
Miami, FL
13h ago

Director of Finance

CoMind
London, UK
13h ago

Electronics Engineering Manager

CoMind
London, UK
13h ago

Director of Information Technology

Zavation Medical Products
13h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Epilepsy(296)Multiple Sclerosis(283)Schizophrenia(268)Parkinson Disease(185)Alzheimer's Disease(179)Parkinson's Disease(163)Alzheimer Disease(119)Stroke(102)Depression(84)Relapsing-Remitting Multiple Sclerosis(84)